Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1662 of 5804
-
Scientists hunt for hidden genes behind rare diseases
Knowledge-focused Recruiting nowRare diseases are conditions affecting a small number of people, requiring specific and often multidisciplinary medical care. There are over 7,000 rare diseases, around 80% of which are genetic in origin. These diseases are generally severe, chronic and progressive, and can consi…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New drug targets rare genetic glitch in advanced cancers
Disease control OngoingThis phase II MATCH treatment trial tests how well MLN0128 (TAK-228) works in treating patients with cancer that has certain genetic changes called mTOR mutations. MLN0128 (TAK-228) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New heart device aims to ease heart failure symptoms
Disease control OngoingThis is a post market trial to be conducted at sites in Germany. The device has CE approval in the EU. The purpose of this observational registry is to collect post market data in consecutive patients treated with the IASD System II, to further evaluate efficacy, safety and quali…
Sponsor: Corvia Medical • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug targets rare cancer mutations in phase II trial
Disease control OngoingThis phase II MATCH treatment trial tests how well MLN0128 (TAK-228) works in treating patients with cancer that has certain genetic changes called TSC1 or TSC2 mutations. MLN0128 (TAK-228) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immunotherapy and chemo join forces against tough lymphoma
Disease control Recruiting nowThis randomized phase I/II trial studies the best dose and side effects of durvalumab and to see how well it works with or without lenalidomide in treating patients with cutaneous or peripheral T cell lymphoma that has come back and does not respond to treatment. Monoclonal antib…
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat prostate cancer
Disease control OngoingThis is a single center, single arm Phase I study to establish the safety and feasibility of intravenously administered lentivirally transduced dual PSMA-specific/TGFβ-resistant CAR modified autologous T cells (CART-PSMA-TGFβRDN cells) in patients with metastatic castrate resista…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Immunotherapy combo shows promise for bladder cancer patients unable to get chemo
Disease control OngoingThis pilot phase I trial studies the side effects of durvalumab and tremelimumab in treating patients with muscle-invasive, high-risk urothelial cancer that cannot be treated with cisplatin-based therapy before surgery. Immunotherapy with monoclonal antibodies, such as durvalumab…
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Tech tool boosts asthma care for city kids
Disease control CompletedThe overall goal of this research study is to test the effectiveness of a multifaceted and multi-level prompting intervention in a real world urban primary care office setting on improving provider-delivered guideline-based asthma care and reducing asthma morbidity among urban ch…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New vaccine combo aims to halt early myeloma
Disease control OngoingThis research study is studying a targeted therapy as a possible treatment for Smoldering Multiple Myeloma. The following intervention will be involved in this study: * Lenalidomide * Citarinostat (CC-96241) * PVX-410
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Prostate cancer radiation showdown: which implant works best?
Disease control OngoingThe purpose of this study is to evaluate the dose of High Dose Rate (HDR) brachytherapy chosen for this study as well as a commonly used alternate form of brachytherapy called low dose rate (or seed) brachytherapy. Investigators would like to understand how these treatments contr…
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Parkinson's pump trial aims to keep Early-Stage patients on their feet
Symptom relief CompletedThe aim of the study is to assess the use of the apomorphine pump in earlier stages of Parkinson' Disease (PD), when motor complications have just developed and before patients are significantly affected in their social and occupational functioning. The investigators hypothesize …
Phase: PHASE3 • Sponsor: Rennes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New daily pill shows promise for spinal muscular atrophy
Disease control CompletedThis is a multi-center, exploratory, non-comparative, and open-label study to investigate the safety, tolerability, PK, and PK/PD relationship of risdiplam in adults, children and infants with Spinal Muscular Atrophy (SMA) previously enrolled in Study BP29420 (Moonfish) with the …
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Kids' garden program could sow seeds for healthier futures
Prevention CompletedThe objective of this study is to implement and test the efficacy of the "Summer Harvest Adventure," a comprehensive garden-based behavioral, social, and environmental intervention for children (ages 8-11 years) residing in low-resource communities.
Phase: NA • Sponsor: Ohio State University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Vitamin B2 and folate may prevent pregnancy hypertension in women with gene variant
Prevention OngoingThe aim of this study is to investigate the role of the 677C→T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene on blood pressure (BP) during pregnancy, and to examine the effect of intervention with riboflavin, alone or in combination with 5-methyltetrahydrof…
Phase: NA • Sponsor: University of Ulster • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Poop pills? no, a colonoscopy with donor stool to fight a deadly transplant complication
Disease control Recruiting nowAcute graft-versus-host-disease (aGvHD) is a typical complication after allogeneic hematopoetic stem cell transplantation (ASCT). About 30-60% of patients after ASCT are affected by aGvHD, which constitutes a relevant burden of morbidity and mortality in these patients. Fecal mi…
Phase: PHASE3 • Sponsor: Medical University of Graz • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Heart pacing during surgery may predict and prevent Post-Op AFib
Prevention Recruiting nowPatients undergoing first time cardiac surgery will undergo rapid atrial pacing prior to initiation of cardiopulmonary bypass to screen for AF inducibility. Patients with inducible AF will be randomized to prophylactic amiodarone treatment versus no treatment. Patients who are no…
Phase: PHASE4 • Sponsor: Stanford University • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Oxygen therapy shows promise for fibromyalgia pain relief
Symptom relief CompletedThe investigators have previously studied the efficacy of hyperbaric oxygen therapy (HBOT) as a treatment for Fibromyalgia syndrome (FMS) in a prospective, active control, crossover clinical trial. The results demonstrated significant amelioration of all FMS symptoms, with signif…
Phase: NA • Sponsor: Assaf-Harofeh Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Robot or scalpel? new study tests best bladder cancer surgery
Disease control CompletedThis is a prospective multicentre randomised controlled trial comparing the outcomes from Intracorporeal RARC (iRARC) with open radical cystectomy (ORC) in patients with bladder cancer. The study will recruit patients with non-muscle invasive bladder cancer (NMIBC) or muscle inva…
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Simple pulse test could spot hidden heart defects in newborns
Knowledge-focused CompletedPersistant hypoxemia in the newborn confers, even isolated, an abnormal clinical situation, that needs to be addressed for an adequate diagnosis and an optimal treatment. If during the first hours of life, hypoxemia is frequent and often transient, beyond that, it is necessary t…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Diabetes prevention program tailored for native men shows promise
Prevention CompletedTo reduce modifiable diabetes risk factors' in overweight and obese AI men residing on the Colville reservation through a community-based, culturally informed intervention, the study specifically aims to: 1. conduct focus groups and interviews with adult members of Colville tribe…
Phase: NA • Sponsor: Washington State University • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC